Reduced ICS use in pregnancy linked to higher hospital asthma exacerbations; history of poor control also increases risk.

How to educate patients with asthma about why it is so important they swap their ‘blue’ salbutamol inhaler for a new ...

The risk for SARS-CoV-2 infection is increased among adults with allergic rhinitis using nasal corticosteroids but not among children.

Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related ...

Background Guidelines recommend Emergency Department (ED) healthcare professionals (HCPs) ensure patients have a supply of inhaled corticosteroid on discharge after an acute asthma presentation. By ...

It will grow to $44.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%.” - The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, August 21, 2025 /EINPresswire / -- "Get ...

• We are confident that quality of life is improved with triple therapy (inhaled corticosteroids (ICS) plus long-acting beta2-agonists (LABA) plus long-acting muscarinic antagonists (LAMA)) compared ...

Setting English primary electronic health data from the Clinical Practice Research Datalink linked with hospital data from Hospital Episode Statistics. Participants 42 820 children aged 5 years or ...

Following the conclusion of the International Chamber of Shipping (ICS) Annual General Meeting and Board Meeting in Athens, which was opened by The Honorable Vassilis Kikilias, Minister of Maritime ...

Stephen Hughes receives research grant funding from the Australian Government Department of Health and Aged Care Medical Research Future Fund, The Australian Research Council and Asthma Australia. He ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. On May 6, 2025, the Global ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca ...